Semaglutide
Semaglutide is an anti-diabetic medication (GLP-1 receptor agonist) sold under brand names Ozempic, Wegovy, and Rybelsus. It treats type 2 diabetes and chronic weight management with once-weekly injection, offering a long duration of action.
Description
Product Introduction
Semaglutide is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.
Semaglutide is used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity. It also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss.
Product Description
- Application Field
- Type 2 diabetes treatment, weight management, cardiovascular protection, peptide drug API
- Packaging
- Custom packaging per client requirements
- Storage Conditions
- -20°C, protected from light, sealed storage
- Shelf Life
- 2 years
Specifications
| Appearance | White to off-white powder |
| Purity (HPLC) | ≥98% |
| Peptide Content | ≥80% |
